Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and ...

Livdelzi belongs to a class of drugs called peroxisome proliferator-activated receptor-delta agonists and is designed to reduce the production of bile acid in the liver, preventing liver damage and ...